Nanobiotix (XPAR:NANO) Ending Cash Position : €75.28 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Nanobiotix Ending Cash Position?

Nanobiotix's Ending Cash Position for the quarter that ended in Dec. 2023 was €75.28 Mil.

Nanobiotix's quarterly Ending Cash Position declined from Dec. 2022 (€41.39 Mil) to Jun. 2023 (€21.63 Mil) but then increased from Jun. 2023 (€21.63 Mil) to Dec. 2023 (€75.28 Mil).

Nanobiotix's annual Ending Cash Position declined from Dec. 2021 (€83.92 Mil) to Dec. 2022 (€41.39 Mil) but then increased from Dec. 2022 (€41.39 Mil) to Dec. 2023 (€75.28 Mil).

Nanobiotix Ending Cash Position Historical Data

The historical data trend for Nanobiotix's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix Ending Cash Position Chart

Nanobiotix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

35.09

119.15

83.92

41.39

75.28

Nanobiotix Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															83.92	63.02	41.39	21.63	75.28

Nanobiotix Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nanobiotix's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	41.388	+	33.895
	=	75.28

Nanobiotix's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	21.63	+	53.653
	=	75.28

Nanobiotix Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nanobiotix's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanobiotix (XPAR:NANO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (XPAR:NANO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

NBTX:USA 5NR:Germany

Address

60 Rue de Wattignies, Paris, FRA, 75012

Website

https://www.nanobiotix.com

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix (XPAR:NANO) Headlines

No Headlines